News

Gill discusses her continuing work to transform clinical trials and improve the patient experience through DCTs.

Companies aim to simplify access to informative patient care data.

How pharma companies can reduce the risk of failure with AI-based innovations.

Wearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.

Organizations aim to advance precision oncology and biomarker-driven research.

Support to focus on two double-blind Phase IIIb clinical studies in the Democratic Republic of Congo and Cote d’Ivoire.

Initiative aims to reduce cancer mortality rates by 50% in the next 25 years.

Mixture to be used for central nervous system clinical trials.

Industry leaders gathered to address the current landscape of data collection in clinical trials.

The ACT EU initiative aims to develop the European Union further as a competitive center for innovative clinical research.

Treatment facility to be the first to evaluate Deltacel for patients with non-small cell lung cancer.

Collaboration to focus on enabling clinicians to open clinical trials at the point of care.

Partnership enables Moderna to leverage Caris' library of de-identified, multi-modal data and analytics.

Company to integrate European diversity data from the UK and demographics data from France and Spain.

New hires expected to reinforce the company's clinical and digital trial expertise.

Move marks commitment to leading the frontier of AI-driven innovation and simulation in life sciences, company says.

Two-thirds of respondents believe setup and training on trial sponsor technology are more problematic than five years ago.

Service expected to offer insights to sponsors conducting clinical trials in any indication in under ten days.

Added feature offers cost savings and the ability to reduce carbon footprint, company says.

CRO commits to achieving Net-Zero Standard by 2035.

Aims to advance innovative treatments for rare diseases.

Companies to collaborate on facilitating clinical trials in historically underserved regions.

Study focused on the impact of several socioeconomic factors, such as insurance coverage and patients' willingness to travel.

Patient organizations gave $22 billion in grants for research, patient services, and access to care over the last five years, says report.

Since the inception of their partnership in 2008, Medidata and the NCI have collaborated across thousands of clinical trials.

Pharma company is the second to join the project.

New module designed to provide simple storage of participant consent.

VaxTRIALS adds a new Latin America base and greater vaccine research depth.